myelomasociety.org
Categoria: Business
99
/ 100 Punteggio di fiducia
Basato sui risultati della scansione al momento dell'analisi
Nessuna minaccia rilevata
È il tuo sito web?
Mostra ai visitatori che il tuo sito è sicuro
Aggiungi il PCrisk Trust Badge, sottoposto a nuova scansione ogni 24 ore per malware e minacce. Un sigillo di sicurezza visibile rassicura i visitatori e questa fiducia può tradursi in più vendite, iscrizioni e chiamate.
Nuove scansioni automatiche
Verificato da oltre 90 motori di sicurezza
WordPress · Shopify · Wix · qualsiasi sito
Ottieni il tuo Trust Badge
Copia e incolla · configurazione rapida
I controlli di sicurezza PCrisk nei tuoi risultati Google
Aggiungi PCrisk come fonte preferita: i nostri report di scansione e le guide alla rimozione avranno priorità su Google.
Aggiungi PCrisk come fonte preferita
Screenshot di myelomasociety.org
Acquisito 17 ago 2026
https://myelomasociety.org
16 anni
Non classificato - Questo sito web non compare nella lista top di Tranco
Non elencato (91 controllati)
✓ Valido (TLS)
Google Cloud (us-east1)
North Charleston, United States
nginx
WordPress
104.196.208.135
Informazioni dominio e WHOIS
Registrar
Squarespace Domains II LLC
Registrato
16 dicembre 2009
Scade
16 dicembre 2026
Name Server
ns-cloud-a2.googledomains.com
DNSSEC
Firmato
Hosting
Google Cloud (us-east1)
Controllo reputazione e minacce
91 motori di sicurezza controllati
0
Non segnalato
Fonti dirette dei database di minacce
Google
Non elencato
Spamhaus DBL
Non elencato
SURBL
Non elencato
Spamhaus ZEN
Non elencato
Barracuda
Non elencato
SpamCop
Non elencato
Spamhaus ZRD
Non elencato
URLhaus
Non elencato
Phishtank
Non elencato
QBMA
Non elencato
Vedi i risultati dettagliati dei motori su VirusTotal
Riepilogo scansione file
Powered by Quttera Engine
61 file scansionati
Nessuna minaccia
61
Rischio basso
0
Rischio medio
0
Rischio alto
0
Nessuna minaccia
Rischio basso
Rischio medio
Rischio alto
www.myelomasociety.org.http-redirect
96 B
Nessuna minaccia
www.myelomasociety.org/?page_id=2928&preview=true
217.2 KB
Nessuna minaccia
www.myelomasociety.org/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/#
312.7 KB
Nessuna minaccia
www.myelomasociety.org/education/#
145.0 KB
Nessuna minaccia
www.myelomasociety.org/imsound/#
156.2 KB
Nessuna minaccia
www.myelomasociety.org/translational-research-award/#
220.5 KB
Nessuna minaccia
www.myelomasociety.org/donate/#
183.9 KB
Nessuna minaccia
www.myelomasociety.org/publications/#
145.3 KB
Nessuna minaccia
www.myelomasociety.org/glo-ims/#
142.2 KB
Nessuna minaccia
Mostra altri 51...
www.myelomasociety.org/events/#
156.3 KB
Nessuna minaccia
www.myelomasociety.org/advocacy/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/advocacy/#
142.6 KB
Nessuna minaccia
www.myelomasociety.org/awards/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/awards/#
142.7 KB
Nessuna minaccia
www.myelomasociety.org/contact/#
141.6 KB
Nessuna minaccia
www.myelomasociety.org/ims-news-room/#
144.0 KB
Nessuna minaccia
www.myelomasociety.org/ims-connect/#
145.2 KB
Nessuna minaccia
www.myelomasociety.org/meeting-materials/#
142.0 KB
Nessuna minaccia
www.myelomasociety.org/about-us/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/about-us/#
144.3 KB
Nessuna minaccia
www.myelomasociety.org/grants/#
143.8 KB
Nessuna minaccia
www.myelomasociety.org/renew-membership/#
202.5 KB
Nessuna minaccia
www.myelomasociety.org/career-development-award/#
185.6 KB
Nessuna minaccia
www.myelomasociety.org/membership/#
142.7 KB
Nessuna minaccia
www.google.com/recaptcha/api.js?hl=en&&ver=7.0.4#038;render=explicit
976 B
Nessuna minaccia
player.vimeo.com/video/1122004834?h=91c3f1bf02
5.0 KB
Nessuna minaccia
www.myelomasociety.org/feed/mp3/#
34.1 KB
Nessuna minaccia
www.myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/#
143.3 KB
Nessuna minaccia
www.myelomasociety.org/events/23rd-ims-annual-meeting/#
147.7 KB
Nessuna minaccia
www.myelomasociety.org/events/novel-immune-therapies-workshop/#
144.8 KB
Nessuna minaccia
www.myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/#
149.2 KB
Nessuna minaccia
www.myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/#
146.8 KB
Nessuna minaccia
www.myelomasociety.org/advocacy/tmap/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/advocacy/tmap/#
144.4 KB
Nessuna minaccia
www.myelomasociety.org/awards/waldenstrom-award/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/awards/waldenstrom-award/#
146.8 KB
Nessuna minaccia
www.myelomasociety.org/awards/ken-anderson-young-investigator-award/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/awards/ken-anderson-young-investigator-award/#
146.6 KB
Nessuna minaccia
www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/#
146.5 KB
Nessuna minaccia
www.myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/#
147.3 KB
Nessuna minaccia
www.myelomasociety.org/officers/masahiro-abe-md-phd/#
145.3 KB
Nessuna minaccia
www.myelomasociety.org/officers/kenneth-anderson-md/#
146.6 KB
Nessuna minaccia
www.myelomasociety.org/officers/suzanne-lentzsch-md-phd/#
146.8 KB
Nessuna minaccia
www.myelomasociety.org/officers/katja-weisel-md/#
147.0 KB
Nessuna minaccia
www.myelomasociety.org/officers/19271/#
146.1 KB
Nessuna minaccia
www.myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/#
145.6 KB
Nessuna minaccia
www.myelomasociety.org/officers/philippe-moreau-md/#
145.2 KB
Nessuna minaccia
www.myelomasociety.org/officers/elena-zamagni-md-phd/#
146.5 KB
Nessuna minaccia
www.myelomasociety.org/officers/noopur-s-raje-md/#
145.0 KB
Nessuna minaccia
www.myelomasociety.org/officers/nikhil-c-munshi-md/#
147.3 KB
Nessuna minaccia
www.myelomasociety.org/officers/jesus-san-miguel-md-phd/#
145.7 KB
Nessuna minaccia
www.myelomasociety.org/officers/shaji-kumar-md/#
144.6 KB
Nessuna minaccia
www.myelomasociety.org/officers/maria-victoria-mateos-md-phd/#
145.9 KB
Nessuna minaccia
www.myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/#
146.6 KB
Nessuna minaccia
www.myelomasociety.org/officers/robert-a-kyle-md/#
145.8 KB
Nessuna minaccia
www.myelomasociety.org/about-us/officers/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/about-us/officers/#
151.2 KB
Nessuna minaccia
www.myelomasociety.org/about-us/member-details/about%3Ablank
60 B
Nessuna minaccia
www.myelomasociety.org/about-us/member-details/#
217.2 KB
Nessuna minaccia
Link esterni e domini
411
Link esterni
Tutto pulito
1
Iframes
Pulito
27
Domini referenziati
Tutto pulito
0
Risorse segnalate
Nessuno rilevato
http://browsehappy.com/Non segnalato
http://myelomasociety.org/about-us/Non segnalato
http://myelomasociety.org/about-us/member-details/Non segnalato
http://myelomasociety.org/about-us/officers/Non segnalato
http://myelomasociety.org/about:blankNon segnalato
http://myelomasociety.org/advocacy/Non segnalato
http://myelomasociety.org/advocacy/tmap/Non segnalato
http://myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/Non segnalato
http://myelomasociety.org/awards/Non segnalato
http://myelomasociety.org/awards/bart-barlogie-young-investigator-award/Non segnalato
http://myelomasociety.org/awards/ken-anderson-young-investigator-award/Non segnalato
http://myelomasociety.org/awards/waldenstrom-award/Non segnalato
http://myelomasociety.org/career-development-award/Non segnalato
http://myelomasociety.org/contact/Non segnalato
http://myelomasociety.org/donate/Non segnalato
Mostra altri 396...
http://myelomasociety.org/education/Non segnalato
http://myelomasociety.org/events/Non segnalato
http://myelomasociety.org/events/23rd-ims-annual-meeting/Non segnalato
http://myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/Non segnalato
http://myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/Non segnalato
http://myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/Non segnalato
http://myelomasociety.org/events/novel-immune-therapies-workshop/Non segnalato
http://myelomasociety.org/glo-ims/Non segnalato
http://myelomasociety.org/grants/Non segnalato
http://myelomasociety.org/ims-connect/Non segnalato
http://myelomasociety.org/ims-news-room/Non segnalato
http://myelomasociety.org/imsound/Non segnalato
http://myelomasociety.org/meeting-materials/Non segnalato
http://myelomasociety.org/membership/Non segnalato
http://myelomasociety.org/officers/19271/Non segnalato
http://myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/Non segnalato
http://myelomasociety.org/officers/elena-zamagni-md-phd/Non segnalato
http://myelomasociety.org/officers/jesus-san-miguel-md-phd/Non segnalato
http://myelomasociety.org/officers/katja-weisel-md/Non segnalato
http://myelomasociety.org/officers/kenneth-anderson-md/Non segnalato
http://myelomasociety.org/officers/maria-victoria-mateos-md-phd/Non segnalato
http://myelomasociety.org/officers/masahiro-abe-md-phd/Non segnalato
http://myelomasociety.org/officers/nikhil-c-munshi-md/Non segnalato
http://myelomasociety.org/officers/noopur-s-raje-md/Non segnalato
http://myelomasociety.org/officers/philippe-moreau-md/Non segnalato
http://myelomasociety.org/officers/robert-a-kyle-md/Non segnalato
http://myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/Non segnalato
http://myelomasociety.org/officers/shaji-kumar-md/Non segnalato
http://myelomasociety.org/officers/suzanne-lentzsch-md-phd/Non segnalato
http://myelomasociety.org/publications/Non segnalato
http://myelomasociety.org/renew-membership/Non segnalato
http://myelomasociety.org/rwlkndntodz70pncjlz+vs5lfhfs7lixda/nQ6BMfy4NA2JV8GvaNOriauzE38L2WqrHhMJJUcx+XNd2b1cxprmEXCC5WRqcvN4kZNMzea4LDY%3DNon segnalato
http://myelomasociety.org/translational-research-award/Non segnalato
http://myelomasociety.org/zotknmvcufmka+gcznuu6s0sonmy8vvthz6jnd4wwup4krocefqzpoqm7cr93knvfnyeidjhbj8t7xaehzwvmjntmqex4cl9vwjx0/baf2tMms%3DNon segnalato
http://tmap.myelomasociety.org/Non segnalato
https://bsky.app/profile/myeloma-society.bsky.socialNon segnalato
https://cdn.jsdelivr.net/npm/tsparticles@1.18.3/dist/tsparticles.min.jsNon segnalato
https://challenges.cloudflare.com/turnstile/v0/api.js?onload%3DturnstileLoadNon segnalato
https://events.jspargo.com/ims26/CUSTOM/DGHOProgram2026.pdfNon segnalato
https://events.jspargo.com/ims26/CUSTOM/IMS2026Program.pdf?__hstc%3D113688920.2b677668b1c0d347e01494227127fa6c.1775135324106.1779466033070.1779705887942.56&%3B__hssc%3D113688920.1.1779705887942&%3B__hsfp%3Dbf1414f9ef3b88063871ea845a26dec4Non segnalato
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarCentralAug.pdfNon segnalato
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarCentralJul.pdfNon segnalato
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarEastAug.pdfNon segnalato
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarEastJun.pdfNon segnalato
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarWestAug.pdfNon segnalato
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarWestJul.pdfNon segnalato
https://fonts.googleapis.com/css2?family%3DOpen+Sans:ital@0%3B1&%3Bfamily%3DPlayfair+Display:ital,wght@0,400%3B0,700%3B1,400%3B1,700&%3Bdisplay%3DswapNon segnalato
https://fonts.gstatic.comNon segnalato
https://ims26.myexpoonline.com/homeNon segnalato
https://myeloma.wpengine.com/about-us/officers/Non segnalato
https://myeloma.wpengine.com/wp-content/uploads/2021/02/COI-Policy-IMS.pdfNon segnalato
https://myeloma.wpengine.com/wp-content/uploads/2021/03/IMSAltLogo.pngNon segnalato
https://myelomasociety.flexigrant.com/startapplication.aspx?id%3D16381Non segnalato
https://myelomasociety.org/grants/ims-career-development-award/Non segnalato
https://myelomasociety.org/past-events/Non segnalato
https://myelomasociety.org/privacy-policy/Non segnalato
https://myelomasociety.org/publications/Non segnalato
https://myelomasociety.org/wp-content/uploads/2021/03/PM-COVID-vaccination-in-MM-guidelines-The-Final.pdfNon segnalato
https://player.vimeo.com/video/1122004834?h%3D91c3f1bf02Non segnalato
https://www.eventcreate.com/e/communitywebinarseries2026Non segnalato
https://www.eventcreate.com/e/fda-ims-joint-workshop2024Non segnalato
https://www.eventcreate.com/e/imsdgho2026Non segnalato
https://www.google.com/recaptcha/api.js?hl%3Den&%3B&%3Bver%3D7.0.4#038%3Brender%3DexplicitNon segnalato
https://www.googletagmanager.com/gtag/js?id%3DAW-11265840522Non segnalato
https://www.googletagmanager.com/gtag/js?id%3DGT-MK9LQQBNon segnalato
https://www.gstatic.com/recaptcha/releases/XOqlk8PL_yVx6IdpLbpXdiLy/recaptcha__en.jsNon segnalato
https://www.linkedin.com/company/19160726/admin/dashboard/Non segnalato
https://www.myelomasociety.orgNon segnalato
https://www.myelomasociety.org/Non segnalato
https://www.myelomasociety.org/?p%3D18549Non segnalato
https://www.myelomasociety.org/?p%3D18605Non segnalato
https://www.myelomasociety.org/?p%3D18607Non segnalato
https://www.myelomasociety.org/?p%3D18610Non segnalato
https://www.myelomasociety.org/?page_id%3D2928&%3Bpreview%3DtrueNon segnalato
https://www.myelomasociety.org/?post_type%3Dpodcast&%3Bp%3D18550&%3Bpreview%3DtrueNon segnalato
https://www.myelomasociety.org/about-us/Non segnalato
https://www.myelomasociety.org/about-us/member-details/Non segnalato
https://www.myelomasociety.org/about-us/member-details/membership-information/Non segnalato
https://www.myelomasociety.org/about-us/officers/Non segnalato
https://www.myelomasociety.org/advocacy/Non segnalato
https://www.myelomasociety.org/advocacy/tmap/Non segnalato
https://www.myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/Non segnalato
https://www.myelomasociety.org/award/amyloid-targeting-car-macrophage-therapy-against-al-amyloidosis/Non segnalato
https://www.myelomasociety.org/award/ancestrality-of-genomic-alterations-in-multiple-myeloma-impact-on-the-clonal-evolution-and-on-the-minimal-residual-disease-dynamics/Non segnalato
https://www.myelomasociety.org/award/apobec3b-as-a-biomarker-and-therapeutic-vulnerability-in-tp53-aberrant-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/application-of-mass-spectrometry-for-the-diagnosis-and-monitoring-of-real-life-patients-with-monoclonal-gammopathies/Non segnalato
https://www.myelomasociety.org/award/armored-cars-to-overcome-sialylation-mediated-resistance-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/batmman-bone-marrow-adipocytes-in-the-multiple-myeloma-niche/Non segnalato
https://www.myelomasociety.org/award/bcl2l1-armored-car-t-cells-overcome-exhaustion-and-enhance-persistence-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/bcma-inkt-car-for-the-treatment-of-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/biomarkers-for-monoclonal-gammopathy-of-undetermined-significance-mgus-and-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/bone-marrow-inflammation-as-driver-of-multiple-myeloma-persistence-and-relapse/Non segnalato
https://www.myelomasociety.org/award/characterizing-the-emergence-of-t-cell-dysfunction-as-a-cause-of-therapy-failure-and-disease-progression-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/chimeric-antigen-receptor-t-cells-secreting-il-12-and-anti-il-6-to-enhance-responses-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/comprehensive-exploration-of-molecular-pathways-and-biomarkers-in-myeloma-induced-bone-disease-a-multi-omics-approach-for-personalized-therapeutic-management/Non segnalato
https://www.myelomasociety.org/award/comprehensive-genomic-and-immune-characterization-of-response-and-resistance-to-daratumumab-based-quadruplet-induction-therapy/Non segnalato
https://www.myelomasociety.org/award/convad-cart-next-generation-bcma-cart-cells-with-modular-targeting-capacities/Non segnalato
https://www.myelomasociety.org/award/correlation-between-unfolded-protein-response-upr-markers-and-thrombosis-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/deciphering-the-human-plasma-cell-niche-and-its-transformation-in-multiple-myeloma-by-highly-multiplexed-tissue-imaging/Non segnalato
https://www.myelomasociety.org/award/defining-the-risk-of-clonal-hematopoiesis-and-therapy-related-myeloid-neoplasms-in-multiple-myeloma-patients-receiving-asct-and-lenalidomide-maintenance/Non segnalato
https://www.myelomasociety.org/award/democratizing-multiple-myeloma-car-t-cell-therapy-by-in-situ-programming-of-virus-specific-t-cells/Non segnalato
https://www.myelomasociety.org/award/destiny-detecting-spatial-heterogeneity-in-multiple-myeloma-patients-through-a-liquid-biopsy-approach/Non segnalato
https://www.myelomasociety.org/award/development-of-an-optimized-dual-targeted-tandem-vh-only-fully-human-car-to-generate-long-term-durable-remission-with-adoptive-cellular-therapy-for-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/development-of-novel-extracellular-vesicle-ev-exosome-based-treatment-for-multiple-myeloma-therapeutic-potential-of-mir125b-containing-osteoblast-derived-evs/Non segnalato
https://www.myelomasociety.org/award/development-of-novel-targeted-therapies-for-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/discover-nutrients-understanding-the-relationship-between-nutrition-and-microbiome-in-mm/Non segnalato
https://www.myelomasociety.org/award/discovering-and-targeting-unprecedented-mitochondrial-vulnerabilities-against-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/dissect-the-mechanisms-by-which-cst6n137d-enhances-the-efficacy-of-car-t-cell-therapy-in-myeloma/Non segnalato
https://www.myelomasociety.org/award/dissecting-and-appraising-novel-mitochondrial-vulnerabilities-against-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/dissecting-the-functional-role-of-apobec3b-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/dissecting-the-mechanisms-of-multiple-myeloma-mm-resistance-to-natural-killer-nk-cells-and-the-role-of-nk-cells-macrophage-interaction-in-mm-immune-evasion/Non segnalato
https://www.myelomasociety.org/award/early-detection-and-intervention-in-smoldering-multiple-myeloma-population-based-screening-and-treatment-edit-smm/Non segnalato
https://www.myelomasociety.org/award/evaluating-nkp30-directed-bispecific-nk-cell-engagers-for-multiple-myeloma-therapy/Non segnalato
https://www.myelomasociety.org/award/evaluation-of-single-nucleotide-polymorphisms-of-brca1-cdkn1a-tp53bp-and-xrcc1-in-multiple-myeloma-patients-undergoing-hematopoietic-stem-cells-transplant-and-their-association-with-clinical-outcom/Non segnalato
https://www.myelomasociety.org/award/evaluation-of-single-nucleotide-variants-in-dna-repair-and-cell-cycle-control-genes-in-multiple-myeloma-patients-undergoing-hematopoietic-stem-cell-transplant-and-their-association-with-clinical-outco/Non segnalato
https://www.myelomasociety.org/award/exploiting-translation-control-vulnerabilities-imposed-by-antibody-secretion-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/exploring-apobecs-as-therapeutic-vulnerabilities-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/flow-cytometry-as-a-tool-for-the-study-of-the-tumor-microenvironment-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/functional-screens-on-single-cell-transcriptomes-of-genotypically-defined-minimal-residual-disease-cells-to-unravel-specific-vulnerabilities-of-treatment-resistant-multiple-myeloma-future/Non segnalato
https://www.myelomasociety.org/award/gck-a-new-therapeutic-target-for-undruggable-ras-in-myeloma-treatment/Non segnalato
https://www.myelomasociety.org/award/gck-inhibition-as-a-new-therapeutical-approach-in-rasmut-myeloma-and-possible-strategy-to-overcome-therapy-resistance/Non segnalato
https://www.myelomasociety.org/award/glutamine-metabolism-as-new-marker-and-diagnostic-tool-for-bone-diseases-in-mm-patients/Non segnalato
https://www.myelomasociety.org/award/how-to-engage-t-cell-in-myeloma/Non segnalato
https://www.myelomasociety.org/award/identify-high-risk-disease-in-multiple-myeloma-through-single-cell-detection-of-highly-proliferative-pr-cells/Non segnalato
https://www.myelomasociety.org/award/identifying-mechanisms-of-response-and-resistance-to-bcma-car-t-therapy-in-multiple-myeloma-and-extramedullary-disease/Non segnalato
https://www.myelomasociety.org/award/immagine/Non segnalato
https://www.myelomasociety.org/award/immune-cell-contribution-to-drug-resistance-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/immunogenomics-guided-adaptive-cellular-therapies-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/immunotherapy-for-multiple-myeloma-a-new-generation-of-chimeric-antigen-receptors-and-immune-checkpoint-blockade/Non segnalato
https://www.myelomasociety.org/award/improving-immune-surveillance-in-high-risk-multiple-myeloma-patients/Non segnalato
https://www.myelomasociety.org/award/improving-prognosis-of-progression-risk-in-multiple-myeloma-precursors-through-single-cell-sequencing-based-genomic-and-immune-microenvironment-profiling-2/Non segnalato
https://www.myelomasociety.org/award/investigating-creb1-signaling-as-a-novel-therapeutic-target-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/investigating-heme-induced-effector-car-t-cells-for-multiple-myeloma-therapy/Non segnalato
https://www.myelomasociety.org/award/investigating-the-impact-of-vaccinations-on-the-development-and-course-of-monoclonal-gammopathies-a-comprehensive-analysis/Non segnalato
https://www.myelomasociety.org/award/investigating-the-molecular-mechanisms-of-microenvironment-dependent-immune-escape-to-natural-killer-cells-in-myeloma-to-uncover-biomarkers-for-rational-combination-treatment-strategie/Non segnalato
https://www.myelomasociety.org/award/investigation-of-the-molecular-mechanism-of-gck-inhibition-as-therapeutic-approach-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/liquid-biopsy-in-myeloma-to-inform-outcome-and-treatment-decisions/Non segnalato
https://www.myelomasociety.org/award/modeling-unraveling-and-beating-acquired-resistance-to-bcma-and-gprc5d-targeted-agents-in-multiple-myeloma-2/Non segnalato
https://www.myelomasociety.org/award/modeling-unraveling-and-beating-acquired-resistance-to-bcma-and-gprc5d-targeted-agents-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/molecular-characterization-and-therapeutic-targeting-of-protein-kinase-d2-in-t414-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/multimodal-investigation-of-myeloma-recognizing-t-cells-their-transcriptional-features-and-clinical-relevance/Non segnalato
https://www.myelomasociety.org/award/nanobody-based-il-18-armored-bcma-baff-r-dual-car-t-cells-to-overcome-treatment-failure-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/novel-immunotherapy-investigation-and-characterization-of-immune-escape-mechanisms-to-natural-killer-cells-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/optimizing-melphalan-dose-among-older-adults-with-multiple-myeloma-receiving-autologous-stem-cell-transplantation/Non segnalato
https://www.myelomasociety.org/award/patterns-of-relapse-from-complete-response-during-different-maintenance-strategies/Non segnalato
https://www.myelomasociety.org/award/pnc-27-a-novel-effective-strategy-for-targeting-the-achilles-heel-of-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/role-of-flow-cytometry-and-especially-its-use-in-the-definition-of-the-measurable-residual-disease-mrd-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/shield-mm-a-modular-multiplex-shrna-platform-to-enhance-functional-persistence-of-academic-anti-bcma-car-t-cells-ari0002h-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/single-cell-dissection-of-autologous-apheresis-products-to-predict-successful-manufacturing-safe-application-and-response-to-chimeric-antigen-receptor-t-cells-in-newly-diagnosed-and-relapsed-myeloma/Non segnalato
https://www.myelomasociety.org/award/spatial-and-deep-learning-approaches-to-predict-early-progression-in-smoldering-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/spatial-and-temporal-tumor-genomic-heterogeneity-in-extramedullary-multiple-myeloma-and-solitary-plasmacytoma-with-minimal-marrow-involvement/Non segnalato
https://www.myelomasociety.org/award/systematic-functional-genomics-characterization-of-17p13del-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/targeting-collagen-lair1-for-improving-multiple-myeloma-therapeutic-efficacy/Non segnalato
https://www.myelomasociety.org/award/targeting-inter-organelle-communication-to-arrest-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/targeting-loss-of-the-tumor-suppressor-tent5c-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/targeting-metabolic-switch-of-high-risk-multiple-myeloma-cells-towards-the-design-of-an-exploratory-approach-for-an-unmet-clinical-need/Non segnalato
https://www.myelomasociety.org/award/targeting-tcf3-addiction-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/targeting-tf-cd142-as-a-new-target-for-car-nk-cell-immunotherapy-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/targeting-the-bone-marrow-niche-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/the-development-of-amyloid-subtype-specific-car-phagocytes-for-al-amyloidosis-therapy/Non segnalato
https://www.myelomasociety.org/award/the-permissive-immune-microenvironment-is-a-critical-regulator-of-disease-progression-from-smm-to-overt-mm-and-defining-these-alterations-is-critical-for-the-development-of-translational-prognostic-a/Non segnalato
https://www.myelomasociety.org/award/transforming-multiple-myeloma-care-in-sub-saharan-africa-developing-a-population-specific-next-generation-sequencing-panel-based-on-long-read-whole-genome-sequencing-to-enhance-treatment-outcomes-in/Non segnalato
https://www.myelomasociety.org/award/uncovering-ferroptosis-mediated-immune-escape-in-del17p-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/unlocking-precision-medicine-in-refractory-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/award/usbcar-t-using-crispr-2-0-to-generate-universal-slamf7-bcma-car-t-cells-for-treating-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/awards/Non segnalato
https://www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/Non segnalato
https://www.myelomasociety.org/awards/ken-anderson-young-investigator-award/Non segnalato
https://www.myelomasociety.org/awards/waldenstrom-award/Non segnalato
https://www.myelomasociety.org/belantamab-mafodotin-bortezomib-and-dexamethasone-vs-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-overall-survival-analysis-and-updated-efficacy-outcomes-of-th/Non segnalato
https://www.myelomasociety.org/belantamab-mafodotin-bortezomib-and-dexamethasone-vs-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-overall-survival-analysis-and-updated-efficacy-outcomes-of-th/#Non segnalato
https://www.myelomasociety.org/career-development-award/Non segnalato
https://www.myelomasociety.org/contact/Non segnalato
https://www.myelomasociety.org/development-of-an-academic-car-t-in-mm-the-spanish-experience/Non segnalato
https://www.myelomasociety.org/development-of-an-academic-car-t-in-mm-the-spanish-experience/#Non segnalato
https://www.myelomasociety.org/do-we-need-pet-ct-to-assess-response-in-mm/Non segnalato
https://www.myelomasociety.org/do-we-need-pet-ct-to-assess-response-in-mm/#Non segnalato
https://www.myelomasociety.org/donate/Non segnalato
https://www.myelomasociety.org/drug-access-in-brazil-equity-actions-between-public-and-private-health-systems/Non segnalato
https://www.myelomasociety.org/drug-access-in-brazil-equity-actions-between-public-and-private-health-systems/#Non segnalato
https://www.myelomasociety.org/education/Non segnalato
https://www.myelomasociety.org/efficacy-and-safety-of-isa-krd-induction-before-response-adapted-consolidation-in-transplant-eligible-newly-diagnosed-multiple-myeloma-an-interim-analysis-of-the-ifm2020-02-midas-study/#Non segnalato
https://www.myelomasociety.org/events/Non segnalato
https://www.myelomasociety.org/events/23rd-ims-annual-meeting/Non segnalato
https://www.myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/Non segnalato
https://www.myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/Non segnalato
https://www.myelomasociety.org/events/novel-immune-therapies-workshop/Non segnalato
https://www.myelomasociety.org/feed/mp3/Non segnalato
https://www.myelomasociety.org/findings-from-the-australian-and-new-zealand-myeloma-and-related-diseases-registry/Non segnalato
https://www.myelomasociety.org/findings-from-the-australian-and-new-zealand-myeloma-and-related-diseases-registry/#Non segnalato
https://www.myelomasociety.org/first-results-of-a-phase-1-first-in-human-dose-escalation-study-of-isb-2001-a-bcmaxcd38xcd3-targeting-trispecific-antibody-in-patients-with-relapsed-refractory-multiple-myeloma-rrmm/Non segnalato
https://www.myelomasociety.org/first-results-of-a-phase-1-first-in-human-dose-escalation-study-of-isb-2001-a-bcmaxcd38xcd3-targeting-trispecific-antibody-in-patients-with-relapsed-refractory-multiple-myeloma-rrmm/#Non segnalato
https://www.myelomasociety.org/frontline-therapy-for-transplant-ineligible-patients-the-european-perspective/Non segnalato
https://www.myelomasociety.org/frontline-therapy-for-transplant-ineligible-patients-the-european-perspective/#Non segnalato
https://www.myelomasociety.org/glo-ims/Non segnalato
https://www.myelomasociety.org/grants/Non segnalato
https://www.myelomasociety.org/grants/ims-awards-for-exemplary-abstracts/Non segnalato
https://www.myelomasociety.org/grants/ims-career-development-award/Non segnalato
https://www.myelomasociety.org/grants/international-myeloma-society-ims-and-paula-and-rodger-riney-foundation-translational-research-grant/Non segnalato
https://www.myelomasociety.org/importance-of-patient-reported-symptoms-and-health-related-quality-of-life-for-drug-approval-in-mm/#Non segnalato
https://www.myelomasociety.org/ims-connect/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-July-3-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-May-1-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-May-15-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-May-8-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-april-10/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-april-17-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-april-24-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-april-3-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-december-12-2025/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-december-19-2025/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-december-5-2025/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-february-13/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-february-20-2026Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-february-27-2026Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-february-6-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-january-16-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-january-2-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-january-23-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-january-30-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-january-9-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-june-12-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-june-19-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-june-26-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-june-5-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-march-13-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-march-27-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-march-6-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-may-22-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-may-29-2026/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-november-14-2025/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-november-21-2025/Non segnalato
https://www.myelomasociety.org/ims-connect/ims-connect-november-28-2025/Non segnalato
https://www.myelomasociety.org/ims-connect/march-20-2026/Non segnalato
https://www.myelomasociety.org/ims-news-room/Non segnalato
https://www.myelomasociety.org/ims-news-room/a-statement-from-ims-president-philippe-moreau-after-the-ims-myeloma-cure-summit-definitions-metrics-and-milestones/Non segnalato
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-asco-and-eha-signal-a-pivotal-moment-in-multiple-myeloma-research/Non segnalato
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-convenes-global-cure-summit-to-chart-the-scientific-path-to-a-myeloma-cure/Non segnalato
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-launches-national-webinar-series-to-support-community-use-of-emerging-immunotherapies-in-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-opens-abstract-submissions-for-23rd-annual-meeting/Non segnalato
https://www.myelomasociety.org/ims-news-room/international-myeloma-to-convene-global-experts-in-warsaw-for-4th-annual-workshop-on-genomics/Non segnalato
https://www.myelomasociety.org/imsound/Non segnalato
https://www.myelomasociety.org/isatuximab-lenalidomide-bortezomib-and-dexamethasone-induction-therapy-for-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma-final-progression-free-survival-analysis-of-part-1-of-a/Non segnalato
https://www.myelomasociety.org/isatuximab-lenalidomide-bortezomib-and-dexamethasone-induction-therapy-for-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma-final-progression-free-survival-analysis-of-part-1-of-a/#Non segnalato
https://www.myelomasociety.org/login/?action%3Dforgot_passwordNon segnalato
https://www.myelomasociety.org/meeting-materials/Non segnalato
https://www.myelomasociety.org/membershipNon segnalato
https://www.myelomasociety.org/membership/Non segnalato
https://www.myelomasociety.org/membership/directory/Non segnalato
https://www.myelomasociety.org/membership/ims-journal/Non segnalato
https://www.myelomasociety.org/officers/19271/Non segnalato
https://www.myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/Non segnalato
https://www.myelomasociety.org/officers/elena-zamagni-md-phd/Non segnalato
https://www.myelomasociety.org/officers/jesus-san-miguel-md-phd/Non segnalato
https://www.myelomasociety.org/officers/katja-weisel-md/Non segnalato
https://www.myelomasociety.org/officers/kenneth-anderson-md/Non segnalato
https://www.myelomasociety.org/officers/maria-victoria-mateos-md-phd/Non segnalato
https://www.myelomasociety.org/officers/masahiro-abe-md-phd/Non segnalato
https://www.myelomasociety.org/officers/nikhil-c-munshi-md/Non segnalato
https://www.myelomasociety.org/officers/noopur-s-raje-md/Non segnalato
https://www.myelomasociety.org/officers/philippe-moreau-md/Non segnalato
https://www.myelomasociety.org/officers/robert-a-kyle-md/Non segnalato
https://www.myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/Non segnalato
https://www.myelomasociety.org/officers/shaji-kumar-md/Non segnalato
https://www.myelomasociety.org/officers/suzanne-lentzsch-md-phd/Non segnalato
https://www.myelomasociety.org/ongoing-clinical-trials-from-the-nordic-group/Non segnalato
https://www.myelomasociety.org/ongoing-clinical-trials-from-the-nordic-group/#Non segnalato
https://www.myelomasociety.org/optimal-therapy-for-young-patients-with-high-risk-disease-the-european-point-of-view/Non segnalato
https://www.myelomasociety.org/optimal-therapy-for-young-patients-with-high-risk-disease-the-european-point-of-view/#Non segnalato
https://www.myelomasociety.org/phase-2-registrational-study-of-anitocabtagene-autoleucel-for-the-treatment-of-patients-with-relapsed-and-or-refractory-multiple-myeloma-preliminary-results-from-the-immagine-1-trial/Non segnalato
https://www.myelomasociety.org/phase-2-registrational-study-of-anitocabtagene-autoleucel-for-the-treatment-of-patients-with-relapsed-and-or-refractory-multiple-myeloma-preliminary-results-from-the-immagine-1-trial/#Non segnalato
https://www.myelomasociety.org/phase-2-study-of-teclistamab-based-induction-regimens-in-patients-with-transplant-eligible-te-newly-diagnosed-multiple-myeloma-ndmm-results-from-the-gmmg-hd10-dsmm-xx-majestec-5-trial/Non segnalato
https://www.myelomasociety.org/phase-2-study-of-teclistamab-based-induction-regimens-in-patients-with-transplant-eligible-te-newly-diagnosed-multiple-myeloma-ndmm-results-from-the-gmmg-hd10-dsmm-xx-majestec-5-trial/#Non segnalato
https://www.myelomasociety.org/phase-3-study-of-teclistamab-tec-in-combination-with-lenalidomide-len-and-tec-alone-versus-len-alone-in-newly-diagnosed-multiple-myeloma-ndmm-as-maintenance-therapy-following-autologous-stem-cel/Non segnalato
https://www.myelomasociety.org/phase-3-study-of-teclistamab-tec-in-combination-with-lenalidomide-len-and-tec-alone-versus-len-alone-in-newly-diagnosed-multiple-myeloma-ndmm-as-maintenance-therapy-following-autologous-stem-cel/#Non segnalato
https://www.myelomasociety.org/prevention-of-infections-during-treatment-with-bispecific-antibodies-and-car-t-cells-in-multiple-myeloma/#Non segnalato
https://www.myelomasociety.org/publications/Non segnalato
https://www.myelomasociety.org/renew-membership/Non segnalato
https://www.myelomasociety.org/resistance-to-bispecific-antibodies/Non segnalato
https://www.myelomasociety.org/resistance-to-bispecific-antibodies/#Non segnalato
https://www.myelomasociety.org/role-of-tandem-autologous-stem-cell-transplantation-for-the-treatment-of-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/role-of-tandem-autologous-stem-cell-transplantation-for-the-treatment-of-multiple-myeloma/#Non segnalato
https://www.myelomasociety.org/safety-and-efficacy-of-standard-of-care-ciltacabtagene-autoleucel-cilta-cel-for-relapsed-refractory-multiple-myeloma-rrmm-real-world-experience-with-updated-follow-up/#Non segnalato
https://www.myelomasociety.org/single-cell-analyses-of-bone-marrow-immune-microenvironment-in-rrmm-subjects-treated-with-mek1-2-inhibitors-reveal-irf1-mediated-ifn-pdl1-signaling-axes/Non segnalato
https://www.myelomasociety.org/single-cell-analyses-of-bone-marrow-immune-microenvironment-in-rrmm-subjects-treated-with-mek1-2-inhibitors-reveal-irf1-mediated-ifn-pdl1-signaling-axes/#Non segnalato
https://www.myelomasociety.org/single-cell-rna-sequencing-of-6-million-tumor-and-immune-cells-in-patients-with-plasma-cell-premalignancy-unveils-co-regulation-of-disease-progression-by-tumor-biology-and-immune-dysregulation/#Non segnalato
https://www.myelomasociety.org/the-ifm2017-03-phase-3-trial-a-dexamethasone-sparing-regimen-with-daratumumab-and-lenalidomide-for-frail-patients-with-newly-diagnosed-multiple-myeloma/Non segnalato
https://www.myelomasociety.org/the-ifm2017-03-phase-3-trial-a-dexamethasone-sparing-regimen-with-daratumumab-and-lenalidomide-for-frail-patients-with-newly-diagnosed-multiple-myeloma/#Non segnalato
https://www.myelomasociety.org/translational-research-award/Non segnalato
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/css/style-simple-red.css?ver%3D4.14.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/css/style.basic.css?ver%3D4.14.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/js/min/plugin/merged/asl.min.js?ver%3D4787Non segnalato
https://www.myelomasociety.org/wp-content/plugins/custom-twitter-feeds/css/ctf-styles.min.css?ver%3D2.6.1Non segnalato
https://www.myelomasociety.org/wp-content/plugins/google-site-kit/dist/assets/js/googlesitekit-consent-mode-86cb52dcb9f2b27ed244.jsNon segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/basic.min.css?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/theme-components.min.css?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/theme.min.css?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/scripts-theme.min.js?ver%3D301fdc9aa6144168f3b854c4c2c8f6d3Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/utils.min.js?ver%3D3f278756f0a3032bed328ff6a9f6c01dNon segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/vendor-theme.min.js?ver%3D7c651d0ba638ce98b9c65141edddd567Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/conditional_logic.min.js?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/gravityforms.min.js?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/jquery.json.min.js?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/placeholders.jquery.min.js?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/browsers.min.css?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/formreset.min.css?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/formsmain.min.css?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/readyclass.min.css?ver%3D2.10.5Non segnalato
https://www.myelomasociety.org/wp-content/plugins/memberpress/css/ui/login.css?ver%3D1.12.17Non segnalato
https://www.myelomasociety.org/wp-content/plugins/memberpress/css/ui/theme.css?ver%3D1.12.17Non segnalato
https://www.myelomasociety.org/wp-content/plugins/memberpress/js/login.js?ver%3D1.12.17Non segnalato
https://www.myelomasociety.org/wp-content/plugins/podlove-podcasting-plugin-for-wordpress/css/admin-font.css?ver%3D4.5.4Non segnalato
https://www.myelomasociety.org/wp-content/plugins/podlove-podcasting-plugin-for-wordpress/css/frontend.css?ver%3D1.0Non segnalato
https://www.myelomasociety.org/wp-content/plugins/podlove-web-player/js/cache.js?ver%3D5.9.2Non segnalato
https://www.myelomasociety.org/wp-content/plugins/podlove-web-player/web-player/embed.js?ver%3D5.9.2Non segnalato
https://www.myelomasociety.org/wp-content/themes/myeloma-society/dist/scripts/main.js?ver%3D1778641861Non segnalato
https://www.myelomasociety.org/wp-content/themes/myeloma-society/dist/styles/main.css?ver%3D1778641860Non segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/01/home3-1000x834.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/02/Jesus-San-Miguel-MD-PhD-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/02/Kenneth-Anderson-MD-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/02/Mateos-Maria-Victoria-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/02/Nikhil-C.-Munshi-MD-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/02/Philippe-Moreau-MD-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/02/Raje-Noopur-1-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/02/Robert-A.-Kyle-MD-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/02/Shaji-Kumar-MD-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/03/IMSMainLogo.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-180x180.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-192x192.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-32x32.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2022/09/211125_SANOFI_LOGO_RGB.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2022/09/AbbVie-Logo_Blue-002.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2022/11/GENE_LOCKUP_Primary_FullColor_RGB-002-2-1.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2022/11/legend_logo_533x260-002-1.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/08/shutterstock_775583896-745x419.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/2.-AbbVie-Logo-DigitalAbbVieLogo_Preferred-DigitalAbbVieLogo_Preferred_Black_TransparentBack-300x52.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/20th-IMS-Annual-Meeting-Abstract-Book.pdfNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/Abe-Headshot-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/FDAIMSWorkshop2024Program-1.pdfNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/FDA_IMS-Joint-Wkshp-780x390-1-745x390.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/JNJ_Logo_SingleLine_Red_RGB-1-002-300x28.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/ReGEN_Science-Tagline-002-300x70.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/Slide1-300x169.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/Usmani.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/Zamagni-Elena-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2023/10/bms_logo_150_rgb_pos-300x42.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/04/Ochi-headshot-1.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/05/TMAP-Logo-scaled.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/06/IMSound-Logo-for-site-scaled.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/06/IMSound-Logo-scaled.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/07/IMSound-Logo-only-v2.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/07/TMAP-Logo-scaled.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/08/JNJ_Logo_SingleLine_Red_CMYK-300x28.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/08/Practical-Insights-2024_1080-x-1080.jpg2_-745x419.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/10/AZ_RGB_H_COL-300x73.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/10/IMSAnnual2024Abstracts.pdfNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/10/Sanofi-logo-RGB-JPG-300x138.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2024/10/bms_logo_300_rgb_pos-300x41.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/04/GSK_Logo_Full_Colour_RGB-300x169.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/07/Full_Caribou_Logo_Dual_R-300x91.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004103-1-scaled.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004129-1-scaled.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004148-2-scaled.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/Chandramouli_Nagarajan.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/IMS-Program-and-Initiatives-2025-Prf9.pdfNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/IMSAnnual2025Abstracts.pdfNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/Lentzsch-Suzanne-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/Natalia-Schutz.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/09/Weisel-Katja-320x410.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/10/24IMSADA_01640-1000x750.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_001072_Panel_Precursor-1000x750.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_001681_Panel_Perrot-1000x568.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_003079_Audience-1000x696.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_004033_Poster-1000x750.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/12/GILEAD_KITE_Logo_Horiz_RGB_012622-300x93.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/12/IMS-2026-Graphics_940x789-745x419.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/12/Pfizer_BU_Oncology_Color_RGB-300x142.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2025/12/Roche_Logo_800px_Blue_RGB_Roche_Logo_RGB-3-300x156.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2026/03/Abbvie-Community-300x114.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2026/03/Community-Webinar-Graphics_940x789-1-745x419.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2026/03/Slide1-1-300x169.pngNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2026/03/Slide1-300x169.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2026/03/images-e1773728008617-300x60.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2026/05/IMS-GLO-Promos_1080x1080-1000x1000.jpgNon segnalato
https://www.myelomasociety.org/wp-content/uploads/2026/07/IMS-2026-Media-Briefing-The-State-of-Multiple-Myeloma-Cure.pdfNon segnalato
https://www.myelomasociety.org/wp-includes/css/dashicons.min.css?ver%3D7.0.4Non segnalato
https://www.myelomasociety.org/wp-includes/js/dist/a11y.min.js?ver%3Daf934e5259bc51b8718eNon segnalato
https://www.myelomasociety.org/wp-includes/js/dist/dom-ready.min.js?ver%3Da06281ae5cf5500e9317Non segnalato
https://www.myelomasociety.org/wp-includes/js/dist/hooks.min.js?ver%3D7496969728ca0f95732dNon segnalato
https://www.myelomasociety.org/wp-includes/js/dist/i18n.min.js?ver%3D781d11515ad3d91786ecNon segnalato
https://www.myelomasociety.org/wp-includes/js/jquery/jquery-migrate.min.js?ver%3D3.4.1Non segnalato
https://www.myelomasociety.org/wp-includes/js/jquery/jquery.min.js?ver%3D3.7.1Non segnalato
https://www.myelomasociety.org/wp-includes/js/underscore.min.js?ver%3D1.13.8Non segnalato
https://www.vanguardngr.com/casino/de/online-casino-ohne-verifizierung/Non segnalato
https://x.com/Myeloma_SocietyNon segnalato
browsehappy.comNon segnalato
bsky.appNon segnalato
cdn.jsdelivr.netNon segnalato
challenges.cloudflare.comNon segnalato
cloud.google.comNon segnalato
developers.google.comNon segnalato
docs.cloud.google.comNon segnalato
events.jspargo.comNon segnalato
fonts.googleapis.comNon segnalato
fonts.gstatic.comNon segnalato
google.comNon segnalato
ims26.myexpoonline.comNon segnalato
myeloma.wpengine.comNon segnalato
myelomasociety.flexigrant.comNon segnalato
myelomasociety.orgNon segnalato
Mostra altri 12...
player.vimeo.comNon segnalato
support.google.comNon segnalato
tmap.myelomasociety.orgNon segnalato
vimeo.comNon segnalato
www.eventcreate.comNon segnalato
www.google.comNon segnalato
www.googletagmanager.comNon segnalato
www.gstatic.comNon segnalato
www.linkedin.comNon segnalato
www.myelomasociety.orgNon segnalato
www.vanguardngr.comNon segnalato
x.comNon segnalato
<iframe title%3D"vimeo-player" src%3D"https://player.vimeo.com/video/1122004834?h%3D91c3f1bf02" width%3D"640" height%3D"360" frameborder%3D"0" allowfullscreen%3D"allowfullscreen">Non segnalato
Panoramica di myelomasociety.org
Descrizione di myelomasociety.org
myelomasociety.org sembra essere il sito web ufficiale della International Myeloma Society, un'organizzazione focalizzata sulla ricerca sul mieloma multiplo, l'istruzione, la sensibilizzazione e l'assistenza clinica. Il branding della homepage, il titolo della pagina e i link di navigazione indicano un'associazione professionale o un'organizzazione in stile non profit al servizio di clinici, ricercatori e membri della comunità del mieloma in tutto il mondo.
In base ai contenuti visibili e alle sezioni collegate, il sito sembra fornire informazioni su incontri annuali, risorse educative, iniziative di ricerca, premi, attività di sensibilizzazione, adesioni e donazioni. La lunga storia di registrazione del dominio e le classificazioni relative a sanità/istruzione/sensibilizzazione sono coerenti con la presenza di una società medica o ONG consolidata, piuttosto che di un sito promozionale temporaneo.
Valutazione sicurezza di myelomasociety.org
Al momento di questa scansione, nessun motore di sicurezza ha segnalato rilevamenti per questo dominio e la scansione malware non ha indicato file contrassegnati tra le pagine controllate. Inoltre, il dominio non risultava elencato nei database di blacklist orientati a malware e phishing verificati, e i link esterni e i domini di riferimento non mostravano elementi contrassegnati nei risultati della scansione forniti.
Anche altri segnali contestuali sembrano favorevoli. Il dominio è registrato da molti anni, il contenuto del sito corrisponde a un'organizzazione orientata alla sanità e alla sensibilizzazione, e lo screenshot mostra un sito web istituzionale coerente piuttosto che schemi comunemente associati a phishing, falsi negozi online o distribuzione di malware. In base ai dati disponibili, non sono state rilevate minacce al momento di questa scansione.
Descrizione tecnica
Il sito utilizza un certificato SSL/TLS valido emesso da Let's Encrypt, con il certificato indicato come valido fino al 2026-10-02. È ospitato su infrastruttura Google Cloud negli Stati Uniti, utilizza il server web nginx e i suoi nameserver sono configurati tramite un'infrastruttura correlata a Google Domains.
DNSSEC sembra essere abilitato e firmato, il che può contribuire a proteggere l'integrità del DNS. Dai dati della scansione forniti non sono emerse preoccupazioni tecniche di sicurezza immediate, sebbene i dettagli esatti dei protocolli TLS supportati non fossero disponibili in questa istantanea.
Catena di reindirizzamento HTTP
301
https://myelomasociety.org/
200
https://www.myelomasociety.org/
Informazioni sul sito web
Popolarità
Cookie
Non classificato
Classifica Tranco
Non nella Top 1M
Storico classifica (30 giorni)
Nessun dato sul ranking disponibile
3
cookie rilevati
Essenziali0
Analitici2
Pubblicitari1
Social0
3
cookie di 1ª parte
0
di 3ª parte (tracker)
Contesta questo punteggio
Per i proprietari del sito
Pensi che questo punteggio sia impreciso?
Se sei il proprietario del sito web e ritieni che i risultati della scansione contengano errori o falsi positivi, puoi inviare una contestazione per una revisione manuale. Il nostro team risponde in genere entro 1-2 giorni lavorativi.
Ancora un passaggio…
Per inviare la tua contestazione per myelomasociety.org, fai clic sul link di verifica che ti abbiamo appena inviato via email. Una volta verificata, la esamineremo entro 1-2 giorni lavorativi.
Questo report è stato generato automaticamente ed è fornito solo a scopo informativo. I risultati si basano su una scansione puntuale e possono contenere falsi positivi o dati incompleti. Questo non costituisce un audit o una certificazione di sicurezza. Nessun fornitore sul mercato può garantire un tasso di rilevamento del 100%. Se ritieni che questo report sia inesatto, ti preghiamo di
inviare una contestazione.
Simili scansionati di recente
Condividi la tua esperienza con questo sito web. Era sicuro? Hai riscontrato problemi?